Category: Press Releases

LyondellBasell publishes 2025 Sustainability Report, Vision to Value: Maintaining Our Focus

HOUSTON, April 14, 2026 (GLOBE NEWSWIRE) — LyondellBasell (NYSE: LYB), a global leader in the chemical industry, has released its 2025 Sustainability Report, Vision to Value: Maintaining Our Focus. The report outlines how LYB maintained strong operational performance, achieved industry‑leading safety performance, and advanced circular and low‑carbon solutions during 2025. “In 2025, despite a challenging environment, […]

Read More

Media OutReach Newswire Appoints Pamela Phua as Managing Partner, Southeast Asia to Champion Singapore and Southeast Asian Brand Expansion into Global Markets

SINGAPORE – Media OutReach Newswire – 14 April 2026 – Media OutReach Newswire, Asia Pacific’s first and only global newswire, has appointed Ms Pamela Phua as Managing Partner, Southeast Asia. This newly created leadership role is designed to accelerate the company’s growth across Singapore, Malaysia, Thailand, Vietnam, Indonesia and the Philippines – and to serve the growing […]

Read More

Bitget Launches New Pre-IPO Product With SpaceX as First Listing

Bitget Launches New Pre-IPO Product With SpaceX as First Listing VICTORIA, Seychelles, April 13, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has launched IPO Prime, introducing a new market structure that enables users to access and trade pre-IPO exposure to global unicorn companies such as SpaceX. Powered by Republic, the launch […]

Read More

CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”), of the important April 21, 2026 lead plaintiff deadline. SO WHAT: If you purchased Corcept common stock […]

Read More

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – NKTR

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nektar Therapeutics (NASDAQ: NKTR) between February 26, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Nektar securities during […]

Read More